Data / Drug companies / Atomoxetine
Atomoxetine: 19 companies and 109 products in the FDA NDC directory
Atomoxetine is listed in the FDA National Drug Code Directory by 19 companies, with 109 products in commercial distribution. 109 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, and the newest product started marketing on July 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 19
- Products
- 109
- Generic (ANDA) products
- 109 (100.0%)
- Application numbers
- 8
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list atomoxetine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 14 | capsule | Generic drugs (ANDA) | March 11, 2021 |
| Aurobindo Pharma Limited | 7 | capsule | Generic drugs (ANDA) | May 30, 2017 |
| AvKARE | 7 | capsule | Generic drugs (ANDA) | April 12, 2022 |
| Bryant Ranch Prepack | 7 | capsule | Generic drugs (ANDA) | July 1, 2025 |
| Camber Pharmaceuticals, Inc. | 7 | capsule | Generic drugs (ANDA) | March 11, 2021 |
| Creekwood Pharmaceuticals LLC | 7 | capsule | Generic drugs (ANDA) | July 6, 2026 |
| Dr. Reddy's Laboratories Limited | 7 | capsule | Generic drugs (ANDA) | February 23, 2018 |
| Glenmark Pharmaceuticals Inc., USA | 7 | capsule | Generic drugs (ANDA) | May 30, 2017 |
| NorthStar Rx LLC | 7 | capsule | Generic drugs (ANDA) | June 1, 2018 |
| NorthStar RxLLC | 7 | capsule | Generic drugs (ANDA) | March 2, 2026 |
| Rising Pharma Holdings, Inc. | 7 | capsule | Generic drugs (ANDA) | May 30, 2017 |
| Strides Pharma Science Limited | 7 | capsule | Generic drugs (ANDA) | July 1, 2025 |
| Teva Pharmaceuticals USA, Inc. | 7 | capsule | Generic drugs (ANDA) | May 30, 2017 |
| Bryant Ranch Prepack | 4 | capsule | Generic drugs (ANDA) | July 1, 2025 |
| American Health Packaging | 2 | capsule | Generic drugs (ANDA) | December 7, 2020 |
| Bryant Ranch Prepack | 2 | capsule | Generic drugs (ANDA) | February 23, 2018 |
| Major Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | February 23, 2018 |
| Remedyrepack Inc. | 1 | capsule | Generic drugs (ANDA) | May 12, 2025 |
| Zydus Pharmaceuticals USA Inc. | 1 | capsule | Generic drugs (ANDA) | June 12, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 109 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 109 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Norepinephrine Reuptake Inhibitor | 109 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.